This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mottet N, van den Bergh RCN, Briers E, Bourke L, Cornford P, De Santis M, et al. EAU - ESTRO - ESUR - SIOG guidelines on prostate cancer 2018. In: European Association of Urology guidelines 2018 Edition Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2018.MottetNvan denBergh RCNBriersEBourkeLCornfordPDe SantisMet alEAU - ESTRO - ESUR - SIOG guidelines on prostate cancer 2018 In: European Association of Urology guidelines 2018 Edition ArnhemThe NetherlandsEuropean Association of Urology Guidelines Office2018Search in Google Scholar
Brizmohun Appayya M, Adshead J, Ahmed HU, Allen C, Bainbridge A, Barrett T, et al. National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting. BJU Int 2018; 122: 13-25. 10.1111/bju.14361BrizmohunAppayya MAdsheadJAhmedHUAllenCBainbridgeABarrettTet alNational implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meetingBJU Int201812213–2510.1111/bju.14361Open DOISearch in Google Scholar
Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: risk factors for failure and death. Urol Oncol 2007; 25: 110-4. 10.1016/j.urolonc.2006.06.003SwansonGPRiggsMHermansMPathologic findings at radical prostatectomy: risk factors for failure and deathUrol Oncol200725110–410.1016/j.urolonc.2006.06.003Open DOISearch in Google Scholar
Godoy G, Tareen BU, Lepor H. Site of positive surgical margins influences biochemical recurrence after radical prostatectomy. BJU Int 2009; 104: 1610-4. 10.1111/j.1464-410X.2009.08688.xGodoyGTareenBULeporHSite of positive surgical margins influences biochemical recurrence after radical prostatectomyBJU Int20091041610–410.1111/j.1464-410X.2009.08688.xOpen DOISearch in Google Scholar
Epstein JI, Partin AW, Potter SR, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000; 56: 283-8. 10.1016/S0090-4295(00)00640-3EpsteinJIPartinAWPotterSRWalshPCAdenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parametersUrology200056283–810.1016/S0090-4295(00)00640-3Open DOISearch in Google Scholar
Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170: 1798-803. 10.1097/01.ju.0000091805.98960.13CagiannosIKarakiewiczPEasthamJAOhoriMRabbaniFGerigkCet alA preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancerJ Urol20031701798–80310.1097/01.ju.0000091805.98960.13Open DOISearch in Google Scholar
Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: (2 Part 1)332-6. 10.1016/S0022-5347(17)38748-7GervasiLAMataJEasleyJDWilbanksJHSeale-HawkinsCCarltonCEet alPrognostic significance of lymph nodal metastases in prostate cancerJ Urol1989142(2 Part 1)332–610.1016/S0022-5347(17)38748-7Open DOISearch in Google Scholar
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011; 185: 869-75. 10.1016/j.juro.2010.10.057EggenerSEScardinoPTWalshPCHanMPartinAWTrockBJet alPredicting 15-year prostate cancer specific mortality after radical prostatectomyJ Urol2011185869–7510.1016/j.juro.2010.10.057405877621239008Open DOISearch in Google Scholar
Morlacco A, Sharma V, Viers BR, Rangel LJ, Carlson RE, Froemming AT, et al. The incremental role of magnetic resonance imaging for prostate cancer staging before radical prostatectomy. Eur Urol 2017; 71: 701-4. 10.1016/j.eururo.2016.08.015MorlaccoASharmaVViersBRRangelLJCarlsonREFroemmingATet alThe incremental role of magnetic resonance imaging for prostate cancer staging before radical prostatectomyEur Urol201771701–410.1016/j.eururo.2016.08.01527576750Open DOISearch in Google Scholar
Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 751-6. 10.1111/j.1464-410X.2005.05394.xWardJFSlezakJMBluteMLBergstralhEJZinckeHRadical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcomeBJU Int200595751–610.1111/j.1464-410X.2005.05394.x15794776Open DOISearch in Google Scholar
Augustin H, Fritz GA, Ehammer T, Auprich M, Pummer K. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tables. Acta Radiol 2009; 50: 562-9. 10.1080/02841850902889846AugustinHFritzGAEhammerTAuprichMPummerKAccuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tablesActa Radiol200950562–910.1080/0284185090288984619455449Open DOISearch in Google Scholar
Gupta RT, Faridi KF, Singh AA, Passoni NM, Garcia-Reyes K, Madden JF, et al. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urol Oncol Semin Orig Investig 2014; 32: 1292-9. 10.1016/j.urolonc.2014.04.017GuptaRTFaridiKFSinghAAPassoniNMGarcia-ReyesKMaddenJFet alComparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomyUrol Oncol Semin Orig Investig2014321292–910.1016/j.urolonc.2014.04.01724863013Open DOISearch in Google Scholar
Rayn KN, Bloom JB, Gold SA, Hale GR, Baiocco JA, Mehralivand S, et al. Added value of multiparametric magnetic resonance imaging to clinical nomograms for predicting adverse pathology in prostate cancer. J Urol 2018; 200: 1041-7. 10.1016/j.juro.2018.05.094RaynKNBloomJBGoldSAHaleGRBaioccoJAMehralivandSet alAdded value of multiparametric magnetic resonance imaging to clinical nomograms for predicting adverse pathology in prostate cancerJ Urol20182001041–710.1016/j.juro.2018.05.094798315929852182Open DOISearch in Google Scholar
Boehmer D, Maingon P, Poortmans P, Baron M-H, Miralbell R, Remouchamps V, et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol 2006; 79: 259-69. 10.1016/j.radonc.2006.05.012BoehmerDMaingonPPoortmansPBaronM-HMiralbellRRemouchampsVet alGuidelines for primary radiotherapy of patients with prostate cancerRadiother Oncol200679259–6910.1016/j.radonc.2006.05.01216797094Open DOISearch in Google Scholar
Mottet N, van der Poel HG, Rouvière O, Matveev VB, Schoots IG, Briers E, et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol 2017; 72: 84-109. 10.1016/j.eururo.2016.12.003MottetNvan derPoel HGRouvièreOMatveevVBSchootsIGBriersEet alThe benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic reviewEur Urol20177284–10910.1016/j.eururo.2016.12.00328126351Open DOISearch in Google Scholar
Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, et al. Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67: 245-53. 10.3322/caac.21391BuyyounouskiMKChoykePLMcKenneyJKSartorOSandlerHMAminMBet alProstate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manualCA Cancer J Clin201767245–5310.3322/caac.21391637509428222223Open DOISearch in Google Scholar
Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al, editors. AJCC cancer staging manual. 8th edition. New York: Springer; 2017.AminMBEdgeSBGreeneFLByrdDRBrooklandRKWashingtonMKet al, editorsAJCC cancer staging manual. 8th editionNew YorkSpringer201710.1007/978-3-319-40618-3Search in Google Scholar
Giganti F, Moore CM, Punwani S, Allen C, Emberton M, Kirkham A. The natural history of prostate cancer on MRI: lessons from an active surveillance cohort. Prostate Cancer Prostatic Dis 2018; 21: 556-63. 10.1038/s41391-018-0058-5GigantiFMooreCMPunwaniSAllenCEmbertonMKirkhamAThe natural history of prostate cancer on MRI: lessons from an active surveillance cohortProstate Cancer Prostatic Dis201821556–6310.1038/s41391-018-0058-530038388Open DOISearch in Google Scholar
Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging - reporting and data system: 2015, Version 2. Eur Urol 2016; 69: 16-40. 10.1016/j.eururo.2015.08.052WeinrebJCBarentszJOChoykePLCornudFHaiderMAMacuraKJet alPI-RADS prostate imaging - reporting and data system: 2015, Version 2Eur Urol20166916–4010.1016/j.eururo.2015.08.052646720726427566Open DOISearch in Google Scholar
Rouvière O, Hartman RP, Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol 2006; 16: 276-84. doi:org/10.1007/s00330-005-2893-8RouvièreOHartmanRPLyonnetDProstate MR imaging at high-field strength: evolution or revolution?Eur Radiol200616276–84doi:org/10.1007/s00330-005-2893-8Open DOISearch in Google Scholar
Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 2014; 39: 1443-8. 10.1002/jmri.24317TurkbeyBMerinoMJGallardoECShahVArasOBernardoMet alComparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathologyJ Magn Reson Imaging2014391443–810.1002/jmri.24317401616624243824Open DOISearch in Google Scholar
Czarniecki M, Caglic I, Grist JT, Gill AB, Lorenc K, Slough RA, et al. Role of PROPELLER-DWI of the prostate in reducing distortion and artefact from total hip replacement metalwork. Eur J Radiol 2018; 102: 213-9. doi:org/10.1016/j.ejrad.2018.03.021CzarnieckiMCaglicIGristJTGillABLorencKSloughRAet alRole of PROPELLER-DWI of the prostate in reducing distortion and artefact from total hip replacement metalworkEur J Radiol2018102213–9doi:org/10.1016/j.ejrad.2018.03021Open DOISearch in Google Scholar
Gill AB, Czarniecki M, Gallagher FA, Barrett T. A method for mapping and quantifying whole organ diffusion-weighted image distortion in MR imaging of the prostate. Sci Rep 2017; 7: 12727. 10.1038/s41598-017-13097-6GillABCzarnieckiMGallagherFABarrettTA method for mapping and quantifying whole organ diffusion-weighted image distortion in MR imaging of the prostateSci Rep201771272710.1038/s41598-017-13097-6562919628983116Open DOISearch in Google Scholar
Barrett T, Turkbey B, Choyke PL. PI-RADS version 2: what you need to know. Clin Radiol 2015; 70: 1165-76. 10.1016/j.crad.2015.06.093BarrettTTurkbeyBChoykePLPI-RADS version 2: what you need to knowClin Radiol2015701165–7610.1016/j.crad.2015.06.093636953326231470Open DOISearch in Google Scholar
Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019; 0232: 1-12. 10.1016/j.eururo.2019.02.033TurkbeyBRosenkrantzABHaiderMAPadhaniARVilleirsGMacuraKJet alProstate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2Eur Urol201902321–1210.1016/j.eururo.2019.02.03330898406Open DOISearch in Google Scholar
Caglic I, Povalej Brzan P, Warren AY, Bratt O, Shah N, Barrett T. Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension. Eur Radiol 2019. [Epub ahead of print]. 10.1007/s00330-019-06070-6CaglicIPovalejBrzan PWarrenAYBrattOShahNBarrettTDefining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extensionEur Radiol2019[Epub ahead of print]. doi10.1007/s00330-019-06070-6671933330887192Open DOISearch in Google Scholar
Thoeny HC, Froehlich JM, Triantafyllou M, Huesler J, Bains LJ, Vermathen P, et al. Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 2014; 273: 125-35. 10.1148/radiol.14132921ThoenyHCFroehlichJMTriantafyllouMHueslerJBainsLJVermathenPet alMetastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imagingRadiology2014273125–3510.1148/radiol.1413292124893049Open DOISearch in Google Scholar
Slough RA, Caglic I, Hansen NL, Patterson AJ, Barrett T. Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality. Clin Radiol 2018; 73: 216.e9-14. 10.1016/j.crad.2017.07.013SloughRACaglicIHansenNLPattersonAJBarrettTEffect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image qualityClin Radiol201873216e9-14. doi10.1016/j.crad.2017.07.01328803622Open DOISearch in Google Scholar
Ullrich T, Quentin M, Schmaltz AK, Arsov C, Rubbert C, Blondin D, et al. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol 2018; 28: 17-23. org/10.1007/s00330-017-4940-7UllrichTQuentinMSchmaltzAKArsovCRubbertCBlondinDet alHyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostateEur Radiol20182817–23org/10.1007/s00330-017-4940-7Open DOISearch in Google Scholar
Caglic I, Barrett T. Optimising prostate mpMRI: prepare for success. Clin Radiol 2019. [Epub ahead of print]. 10.1016/j.crad.2018.12.003CaglicIBarrettTOptimising prostate mpMRI: prepare for successClin Radiol2019[Epub ahead of print]. doi10.1016/j.crad.2018.12.00330611559Open DOISearch in Google Scholar
Dyde R, Chapman AH, Gale R, Mackintosh A, Tolan DJM. Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butyl-bromide. Clin Radiol 2008; 63: 739-43. org/10.1016/j.crad.2008.02.008DydeRChapmanAHGaleRMackintoshATolanDJMPrecautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butyl-bromideClin Radiol200863739–43org/10.1016/j.crad.2008.02.008Open DOISearch in Google Scholar
Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The prostatic capsule. Am J Surg Pathol 1989; 13: 21-7. 10.1097/00000478-19890100000003AyalaAGRoJYBabaianRTroncosoPGrignonDJThe prostatic capsuleAm J Surg Pathol19891321–710.1097/00000478-19890100000003Open DOISearch in Google Scholar
McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988; 12: 619-33. 10.1097/00000478-198808000-00003McNealJE.Normal histology of the prostateAm J Surg Pathol198812619–3310.1097/00000478-198808000-000032456702Open DOISearch in Google Scholar
Ball MW, Partin AW, Epstein JI. Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further PT3 subclassification. Urology 2015; 85: 161-4. org/10.1016/j.urology.2014.08.025BallMWPartinAWEpsteinJIExtent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further PT3 subclassificationUrology201585161–4org/10.1016/j.urology.2014.08.025Open DOISearch in Google Scholar
Rosenkrantz AB, Shanbhogue AK, Wang A, Kong MX, Babb JS, Taneja SS. Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: assessment at an optimal threshold. J Magn Reson Imaging 2016; 43: 990-7. 10.1002/jmri.25040RosenkrantzABShanbhogueAKWangAKongMXBabbJSTanejaSSLength of capsular contact for diagnosing extraprostatic extension on prostate MRI: assessment at an optimal thresholdJ Magn Reson Imaging201643990–710.1002/jmri.2504026395278Open DOISearch in Google Scholar
Eifler JB, Feng Z, Lin BM, Partin MT, Humphreys EB, Han M, et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int 2013; 111: 22-9. 10.1111/j.1464-410X.2012.11324.xEiflerJBFengZLinBMPartinMTHumphreysEBHanMet alAn updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011BJU Int201311122–910.1111/j.1464-410X.2012.11324.x387647622834909Open DOISearch in Google Scholar
Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 2013; 268: 144-52. 10.1148/radiol.13121325TurkbeyBManiHArasOHoJHoangARastinehadARet alProstate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?Radiology2013268144–5210.1148/radiol.13121325368945023468576Open DOISearch in Google Scholar
de Rooij M, Hamoen EHJ, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol 2016; 70: 233-45. 10.1016/j.eururo.2015.07.029deRooij MHamoenEHJWitjesJABarentszJORoversMMAccuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysisEur Urol201670233–4510.1016/j.eururo.2015.07.02926215604Open DOISearch in Google Scholar
Lawrence EM, Gallagher FA, Barrett T, Warren AY, Priest AN, Goldman DA, et al. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate - or high-risk prostate cancer. AJR Am J Roentgenol 2014; 203: W280-6. 10.2214/AJR.13.11754LawrenceEMGallagherFABarrettTWarrenAYPriestANGoldmanDAet alPreoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate - or high-risk prostate cancerAJR Am J Roentgenol2014203W280–610.2214/AJR.13.1175425148185Open DOISearch in Google Scholar
Boesen L, Chabanova E, Løgager V, Balslev I, Mikines K, Thomsen HS. Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology. Eur Radiol 2015; 25: 1776-85. 10.1007/s00330-014-3543-9BoesenLChabanovaELøgagerVBalslevIMikinesKThomsenHSProstate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathologyEur Radiol2015251776–8510.1007/s00330-014-3543-925504428Open DOISearch in Google Scholar
Schieda N, Quon JS, Lim C, El-Khodary M, Shabana W, Singh V, et al. Evaluation of the European Society of Urogenital Radiology (ESUR) PI-RADS scoring system for assessment of extra-prostatic extension in prostatic carcinoma. Eur J Radiol 2015; 84: 1843-8. 10.1016/j.ejrad.2015.06.016SchiedaNQuonJSLimCEl-KhodaryMShabanaWSinghVet alEvaluation of the European Society of Urogenital Radiology (ESUR) PI-RADS scoring system for assessment of extra-prostatic extension in prostatic carcinomaEur J Radiol2015841843–810.1016/j.ejrad.2015.06.01626137904Open DOISearch in Google Scholar
Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, et al. Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer. J Urol 2015; 193: 46672. 10.1016/j.juro.2014.08.084BacoERudEVlatkovicLSvindlandAEggesbøHBHungAJet alPredictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancerJ Urol20151934667210.1016/j.juro.2014.08.08425150643Open DOISearch in Google Scholar
Woo S, Kim SY, Cho JY, Kim SH. Length of capsular contact on prostate MRI as a predictor of extracapsular extension: which is the most optimal sequence? Acta Radiol 2017; 58: 489-97. 10.1177/0284185116658684WooSKimSYChoJYKimSHLength of capsular contact on prostate MRI as a predictor of extracapsular extension: which is the most optimal sequence?Acta Radiol201758489–9710.1177/028418511665868427439401Open DOISearch in Google Scholar
Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Yoshida S, Saito K, et al. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI diagnosis for extracapsular extension of prostate cancer. AJR Am J Roentgenol 2017; 209: W76-84. org/10.2214/AJR.16.17163MatsuokaYIshiokaJTanakaHKimuraTYoshidaSSaitoKet alImpact of the Prostate Imaging Reporting and Data System, Version 2, on MRI diagnosis for extracapsular extension of prostate cancerAJR Am J Roentgenol2017209W76–84org/10.2214/AJR.16.17163Open DOISearch in Google Scholar
Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergenvan de Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011; 259: 453-61. 10.1148/radiol.11091409HambrockTSomfordDMHuismanHJvan OortIMWitjesJAHulsbergenvande Kaa CAet alRelationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancerRadiology2011259453–6110.1148/radiol.1109140921502392Open DOISearch in Google Scholar
Verma S, Rajesh A, Morales H, Lemen L, Bills G, Delworth M, et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011; 196: 374-81. 10.2214/AJR.10.4441VermaSRajeshAMoralesHLemenLBillsGDelworthMet alAssessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomyAJR Am J Roentgenol2011196374–8110.2214/AJR.10.444121257890Open DOISearch in Google Scholar
Kim CK, Park SY, Park JJ, Park BK. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer. AJR Am J Roentgenol 2014; 202: W270-6. 10.2214/AJR.13.11333KimCKParkSYParkJJParkBKDiffusion-weighted MRI as a predictor of extracapsular extension in prostate cancerAJR Am J Roentgenol2014202W270–610.2214/AJR.13.1133324555624Open DOISearch in Google Scholar
Woo S, Cho JY, Kim SY, Kim SH. Extracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imaging. AJR Am J Roentgenol 2015; 204: W168-75. 10.2214/AJR.14.12939WooSChoJYKimSYKimSHExtracapsular extension in prostate cancer: added value of diffusion-weighted MRI in patients with equivocal findings on T2-weighted imagingAJR Am J Roentgenol2015204W168–7510.2214/AJR.14.1293925615777Open DOISearch in Google Scholar
Giganti F, Coppola A, Ambrosi A, Ravelli S, Esposito A, Freschi M, et al. Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: development and external validation of a nomogram of clinical use. Urol Oncol Semin Orig Investig 2016; 34: 291. e9-17. 10.1016/j.urolonc.2016.02.015GigantiFCoppolaAAmbrosiARavelliSEspositoAFreschiMet alApparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: development and external validation of a nomogram of clinical useUrol Oncol Semin Orig Investig201634291e9-17. doi10.1016/j.urolonc.2016.02.01526992933Open DOISearch in Google Scholar
Barrett T, Priest AN, Lawrence EM, Goldman DA, Warren AY, Gnanapragasam VJ, et al. Ratio of tumor to normal prostate tissue apparent diffusion coefficient as a method for quantifying DWI of the prostate. AJR Am J Roentgenol 2015; 205: W585-93. 10.2214/AJR.15.14338BarrettTPriestANLawrenceEMGoldmanDAWarrenAYGnanapragasamVJet alRatio of tumor to normal prostate tissue apparent diffusion coefficient as a method for quantifying DWI of the prostateAJR Am J Roentgenol2015205W585–9310.2214/AJR.15.1433826587948Open DOISearch in Google Scholar
Rosenkrantz AB, Neil J, Kong X, Melamed J, Babb JS, Taneja SS, et al. Prostate cancer: comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol 2010; 194: 446-52. 10.2214/AJR.09.3217RosenkrantzABNeilJKongXMelamedJBabbJSTanejaSSet alProstate cancer: comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detectionAJR Am J Roentgenol2010194446–5210.2214/AJR.09.321720093608Open DOISearch in Google Scholar
Itatani R, Namimoto T, Takaoka H, Katahira K, Morishita S, Kitani K, et al. Extracapsular extension of prostate cancer: diagnostic value of combined multiparametric magnetic resonance imaging and isovoxel 3-dimensional T2-weighted imaging at 1.5 T. J Comput Assist Tomogr 2015; 39: 37-43. 10.1097/RCT.0000000000000172ItataniRNamimotoTTakaokaHKatahiraKMorishitaSKitaniKet alExtracapsular extension of prostate cancer: diagnostic value of combined multiparametric magnetic resonance imaging and isovoxel 3-dimensional T2-weighted imaging at 1.5 TJ Comput Assist Tomogr20153937–4310.1097/RCT.000000000000017225340587Open DOISearch in Google Scholar
Liberatore M, Delongchamps NB, Eiss D, Beuvon F, Zerbib M, Flam T, et al. Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria? Eur J Radiol 2011; 81: e591-7. 10.1016/j.ejrad.2011.06.056LiberatoreMDelongchampsNBEissDBeuvonFZerbibMFlamTet alEndorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria?Eur J Radiol201181e591–710.1016/j.ejrad.2011.06.05621871750Open DOISearch in Google Scholar
Jäderling F, Nyberg T, Öberg M, Carlsson S, Skorpil M, Blomqvist L. Accuracy in local staging of prostate cancer by adding a three-dimensional T2-weighted sequence with radial reconstructions in magnetic resonance imaging. Acta Radiol Open 2018; 7: 205846011875460. 10.1177/2058460118754607JäderlingFNybergTÖbergMCarlssonSSkorpilMBlomqvistLAccuracy in local staging of prostate cancer by adding a three-dimensional T2-weighted sequence with radial reconstructions in magnetic resonance imagingActa Radiol Open2018720584601187546010.1177/2058460118754607581097729456872Open DOISearch in Google Scholar
Peng Y, Schmid-Tannwald C, Wang S, Antic T, Jiang Y, Eggener S, et al. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 2013; 267: 797-806. 10.1148/radiol.13121319PengYSchmid-TannwaldCWangSAnticTJiangYEggenerSet alSeminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imagingRadiology2013267797–80610.1148/radiol.13121319694001423440325Open DOISearch in Google Scholar
Chan KK, Choi D, Byung KP, Ghee YK, Hyo KL. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging 2008; 28: 963-9. 10.1002/jmri.21531ChanKKChoiDByungKPGheeYKHyoKLDiffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial resultsJ Magn Reson Imaging200828963–910.1002/jmri.2153118821631Open DOISearch in Google Scholar
Potter SR, Epstein JI, Partin AW. Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. Rev Urol 2000; 2: 190-5. PMID: 16985773PotterSREpsteinJIPartinAWSeminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implicationsRev Urol20002190–5PMID: 16985773Search in Google Scholar
Wang L, Hricak H, Kattan MW, Chen HN, Kuroiwa K, Eisenberg HF, et al. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 2007; 242: 182-8. 10.1148/radiol.2421051254WangLHricakHKattanMWChenHNKuroiwaKEisenbergHFet alPrediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogramRadiology2007242182–810.1148/radiol.242105125417090712Open DOISearch in Google Scholar
Grivas N, Hinnen K, de Jong J, Heemsbergen W, Moonen L, Witteveen T, et al. Seminal vesicle invasion on multi-parametric magnetic resonance imaging: correlation with histopathology. Eur J Radiol 2018; 98: 107-12. 10.1016/j.ejrad.2017.11.013GrivasNHinnenKde JongJHeemsbergenWMoonenLWitteveenTet alSeminal vesicle invasion on multi-parametric magnetic resonance imaging: correlation with histopathologyEur J Radiol201898107–1210.1016/j.ejrad.2017.11.01329279147Open DOISearch in Google Scholar
Roethke M, Kaufmann S, Kniess M, Ketelsen D, Claussen CD, Schlemmer HP, et al. Seminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imaging. Urol Int 2014; 92: 294-9. 10.1159/000353968RoethkeMKaufmannSKniessMKetelsenDClaussenCDSchlemmerHPet alSeminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imagingUrol Int201492294–910.1159/00035396824296943Open DOISearch in Google Scholar
Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993; 17: 1252-61. 10.1097/00000478-199312000-00006OhoriMScardinoPTLapinSLSeale-HawkinsCLinkJWheelerTMThe mechanisms and prognostic significance of seminal vesicle involvement by prostate cancerAm J Surg Pathol1993171252–6110.1097/00000478-199312000-000068238732Open DOISearch in Google Scholar
Jung DC, Lee HJ, Kim SH, Choe GY, Lee SE. Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions. J Magn Reson Imaging 2008; 28: 144-50. 10.1002/jmri.21422JungDCLeeHJKimSHChoeGYLeeSEPreoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesionsJ Magn Reson Imaging200828144–5010.1002/jmri.2142218500714Open DOISearch in Google Scholar
Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I, et al. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 2013; 267: 797-806. 10.1148/radiol.13121319SoyluFNPengYJiangYWangSSchmid-TannwaldCSethiIet alSeminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imagingRadiology2013267797–80610.1148/radiol.13121319694001423440325Open DOISearch in Google Scholar
Gofrit ON, Zorn KC, Taxy JB, Zagaja GP, Steinberg GD, Shalhav AL. The dimensions and symmetry of the seminal vesicles. J Robot Surg 2009; 3: 29-33. 10.1007/s11701-009-0134-xGofritONZornKCTaxyJBZagajaGPSteinbergGDShalhavALThe dimensions and symmetry of the seminal vesiclesJ Robot Surg2009329–3310.1007/s11701-009-0134-x27628450Open DOISearch in Google Scholar
Saliken JC, Gray RR, Donnelly BJ, Owen R, White LJ, Ali-Ridha N, et al. Extraprostatic biopsy improves the staging of localized prostate cancer. Can Assoc Radiol J 2000; 51: 114-20. PMID: 10786920SalikenJCGrayRRDonnellyBJOwenRWhiteLJAli-RidhaNet alExtraprostatic biopsy improves the staging of localized prostate cancerCan Assoc Radiol J200051114–20PMID: 10786920Search in Google Scholar
Barrett T, Tanner J, Gill AB, Slough RA, Wason J, Gallagher FA. The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI. Eur Radiol 2017; 27: 5236-43. 10.1007/s00330-017-4905-xBarrettTTannerJGillABSloughRAWasonJGallagherFAThe longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRIEur Radiol2017275236–4310.1007/s00330-017-4905-x567411928677052Open DOISearch in Google Scholar
Medved M, Sammet S, Yousuf A, Oto A. MR Imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation. Radiology 2014; 271: 452-60. 10.1148/radiol.14131374MedvedMSammetSYousufAOtoAMR Imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluationRadiology2014271452–6010.1148/radiol.14131374461090424495265Open DOISearch in Google Scholar
Shin T, Kaji Y, Shukuya T, Nozaki M, Soh S, Okada H. Significant changes of T2 value in the peripheral zone and seminal vesicles after ejaculation. Eur Radiol 2018; 28: 1009-15. 10.1007/s00330-017-5077-4ShinTKajiYShukuyaTNozakiMSohSOkadaHSignificant changes of T2 value in the peripheral zone and seminal vesicles after ejaculationEur Radiol2018281009–1510.1007/s00330-017-5077-428986624Open DOISearch in Google Scholar
Kabakus IM, Borofsky S, Mertan FV, Greer M, Daar D, Wood BJ, et al. Does abstinence from ejaculation before prostate MRI improve evaluation of the seminal vesicles? AJR Am J Roentgenol 2016; 207: 1205-9. 10.2214/AJR.16.16278KabakusIMBorofskySMertanFVGreerMDaarDWoodBJet alDoes abstinence from ejaculation before prostate MRI improve evaluation of the seminal vesicles?AJR Am J Roentgenol20162071205–910.2214/AJR.16.16278781516227657193Open DOISearch in Google Scholar
McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology 2010; 254: 31-46. 10.1148/radiol.2541090361McMahonCJRofskyNMPedrosaILymphatic metastases from pelvic tumors: anatomic classification, characterization, and stagingRadiology201025431–4610.1148/radiol.254109036120032141Open DOISearch in Google Scholar
Joniau S, Van den Bergh L, Lerut E, Deroose CM, Haustermans K, Oyen R, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013; 63: 450-8. 10.1016/j.eururo.2012.06.057JoniauSVanden Bergh LLerutEDerooseCMHaustermansKOyenRet alMapping of pelvic lymph node metastases in prostate cancerEur Urol201363450–810.1016/j.eururo.2012.06.05722795517Open DOISearch in Google Scholar
Briganti A, Suardi N, Capogrosso P, Passoni N, Freschi M, Di Trapani E, et al. Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum. Prostate 2012; 72: 186-92. 10.1002/pros.21420BrigantiASuardiNCapogrossoPPassoniNFreschiMDiTrapani Eet alLymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneumProstate201272186–9210.1002/pros.2142021538428Open DOISearch in Google Scholar
Barentsz JO, Severens JL, Hoogeveen YL, Hövels AM, Adang EM, Jager GJ, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 2008; 63: 387-95. 10.1016/j.crad.2007.05.022BarentszJOSeverensJLHoogeveenYLHövelsAMAdangEMJagerGJet alThe diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysisClin Radiol200863387–9510.1016/j.crad.2007.05.02218325358Open DOISearch in Google Scholar
Vag T, Heck MM, Beer AJ, Souvatzoglou M, Weirich G, Holzapfel K, et al. Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT. Eur Radiol 2014; 24: 1821-6. 10.1007/s00330-014-3240-8VagTHeckMMBeerAJSouvatzoglouMWeirichGHolzapfelKet alPreoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CTEur Radiol2014241821–610.1007/s00330-014-3240-824889997Open DOISearch in Google Scholar
Eiber M, Beer AJ, Holzapfel K, Tauber R, Ganter C, Weirich G, et al. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging. Invest Radiol 2010; 45: 15-23. 10.1097/RLI.0b013e3181bbdc2fEiberMBeerAJHolzapfelKTauberRGanterCWeirichGet alPreliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imagingInvest Radiol20104515–2310.1097/RLI.0b013e3181bbdc2f19996762Open DOISearch in Google Scholar
Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, et al. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in 11C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 2011; 13: 352-61. 10.1007/s11307-010-0337-6BeerAJEiberMSouvatzoglouMHolzapfelKGanterCWeirichGet alRestricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in 11C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancerMol Imaging Biol201113352–6110.1007/s11307-010-0337-620490932Open DOISearch in Google Scholar
Vallini V, Ortori S, Boraschi P, Manassero F, Gabelloni M, Faggioni L, et al. Staging of pelvic lymph nodes in patients with prostate cancer: usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR system. Eur J Radiol Open 2016; 3: 16-21. 10.1016/j.ejro.2015.11.004ValliniVOrtoriSBoraschiPManasseroFGabelloniMFaggioniLet alStaging of pelvic lymph nodes in patients with prostate cancer: usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR systemEur J Radiol Open2016316–2110.1016/j.ejro.2015.11.004481185527069974Open DOISearch in Google Scholar
Roy C, Bierry G, Matau A, Bazille G, Pasquali R. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 2010; 20: 1803-11. 10.1007/s00330-010-1736-4RoyCBierryGMatauABazilleGPasqualiRValue of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 TEur Radiol2010201803–1110.1007/s00330-010-1736-420182732Open DOISearch in Google Scholar
Caglic I, Barrett T. Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer. Transl Androl Urol 2018; 7: 814-23. 10.21037/tau.2018.08.04CaglicIBarrettTDiffusion-weighted imaging (DWI) in lymph node staging for prostate cancerTransl Androl Urol20187814–2310.21037/tau.2018.08.04621262530456184Open DOISearch in Google Scholar
Abdel Razek AAK, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006; 16: 1468-77. 10.1007/s00330-005-0133-xAbdelRazek AAKSolimanNYElkhamarySAlsharawayMKTawfikARole of diffusion-weighted MR imaging in cervical lymphadenopathyEur Radiol2006161468–7710.1007/s00330-005-0133-x16557366Open DOISearch in Google Scholar
Muenzel D, Duetsch S, Fauser C, Slotta-Huspenina J, Gaa J, Rummeny EJ, et al. Diffusion-weighted magnetic resonance imaging in cervical lymphadenopathy: report of three cases of patients with bartonella henselae infection mimicking malignant disease. Acta Radiol 2009; 50: 914-6. 10.1080/02841850903061445MuenzelDDuetschSFauserCSlotta-HuspeninaJGaaJRummenyEJet alDiffusion-weighted magnetic resonance imaging in cervical lymphadenopathy: report of three cases of patients with bartonella henselae infection mimicking malignant diseaseActa Radiol200950914–610.1080/0284185090306144519636985Open DOISearch in Google Scholar
Kwee TC, Takahara T, Luijten PR, Nievelstein RAJ. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010; 75: 215-20. 10.1016/j.ejrad.2009.03.026KweeTCTakaharaTLuijtenPRNievelsteinRAJADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literatureEur J Radiol201075215–2010.1016/j.ejrad.2009.03.02619375259Open DOISearch in Google Scholar
Braithwaite AC, Dale BM, Boll DT, Merkle EM. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009; 250: 459-65. 10.1148/radiol.2502080849BraithwaiteACDaleBMBollDTMerkleEMShort- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomenRadiology2009250459–6510.1148/radiol.250208084919095786Open DOISearch in Google Scholar
Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 2011; 33: 128-35. 10.1002/jmri.22395RosenkrantzABOeiMBabbJSNiverBETaouliBDiffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 TeslaJ Magn Reson Imaging201133128–3510.1002/jmri.2239521182130Open DOISearch in Google Scholar
Sadinski M, Medved M, Karademir I, Wang S, Peng Y, Jiang Y, et al. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate. Abdom Imaging 2015; 40: 2523-8. 10.1007/s00261-015-0396-xSadinskiMMedvedMKarademirIWangSPengYJiangYet alShort-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostateAbdom Imaging2015402523–810.1007/s00261-015-0396-x491874725805558Open DOISearch in Google Scholar
von Below C, Daouacher G, Wassberg C, Grzegorek R, Gestblom C, Sörensen J, et al. Validation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancer. Clin Radiol 2016; 71: 328-34. 10.1016/j.crad.2015.12.001vonBelow CDaouacherGWassbergCGrzegorekRGestblomCSörensenJet alValidation of 3 T MRI including diffusion-weighted imaging for nodal staging of newly diagnosed intermediate- and high-risk prostate cancerClin Radiol201671328–3410.1016/j.crad.2015.12.00126774372Open DOISearch in Google Scholar
Sushentsev N, Martin H, Rimmer Y, Barrett T. Added value of diffusion-weighted MRI for nodal radiotherapy planning in pelvic malignancies. Clin Transl Oncol 2019. [Epub ahead of print]. doi.org/10.1007/s12094-019-02068-0SushentsevNMartinHRimmerYBarrettTAdded value of diffusion-weighted MRI for nodal radiotherapy planning in pelvic malignanciesClin Transl Oncol2019[Epub ahead of print]doi.org/10.1007/s12094-019-02068-0Open DOISearch in Google Scholar
Zacharias C, Kunder C, Giesel F, Daniel B, Hatami N, Harrison C, et al. Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer. Radiology 2018; 288: 495-505. org/10.1148/radiol.2018172232ZachariasCKunderCGieselFDanielBHatamiNHarrisonCet alGallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancerRadiology2018288495–505org/10.1148/radiol.2018172232Open DOISearch in Google Scholar
Freitag MT, Radtke JP, Hadaschik BA, Kopp-Schneider A, Eder M, Kopka K, et al. Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging 2016; 43: 70-83. 10.1007/s00259-015-3206-3FreitagMTRadtkeJPHadaschikBAKopp-SchneiderAEderMKopkaKet alComparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancerEur J Nucl Med Mol Imaging20164370–8310.1007/s00259-015-3206-326508290Open DOISearch in Google Scholar
Baltzer P, Kenner L, Hartenbach M, Mitterhauser M, Goldner GM, Grahovac M, et al. PSMA Ligand PET/MRI for primary prostate cancer: staging performance and clinical impact. Clin Cancer Res 2018; 24: 6300-7. 10.1158/1078-0432.ccr-18-0768BaltzerPKennerLHartenbachMMitterhauserMGoldnerGMGrahovacMet alPSMA Ligand PET/MRI for primary prostate cancer: staging performance and clinical impactClin Cancer Res2018246300–710.1158/1078-0432.ccr-18-076830139879Open DOISearch in Google Scholar
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-9. 10.1056/NEJMoa022749HarisinghaniMGBarentszJHahnPFDesernoWMTabatabaeiSvan deKaa CHet alNoninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med20033482491–910.1056/NEJMoa02274912815134Open DOISearch in Google Scholar
Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 2013; 64: 953-60. 10.1016/j.eururo.2013.07.032BirkhäuserFDStuderUEFroehlichJMTriantafyllouMBainsLJPetraliaGet alCombined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancerEur Urol201364953–6010.1016/j.eururo.2013.07.03223916692Open DOISearch in Google Scholar
Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55: 761-9. 10.1016/j.eururo.2008.12.034ThoenyHCTriantafyllouMBirkhaeuserFDFroehlichJMTsheringDWBinserTet alCombined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patientsEur Urol200955761–910.1016/j.eururo.2008.12.03419144456Open DOISearch in Google Scholar
Fortuin AS, Brüggemann R, van der Linden J, Panfilov I, Israël B, Scheenen TWJ, et al. Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block. Wiley Interdiscip Rev Nanomedicine Nanobiotechnology 2018; 10: e1471. 10.1002/wnan.1471FortuinASBrüggemannRvan derLinden JPanfilovIIsraëlBScheenenTWJet alUltra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the blockWiley Interdiscip Rev Nanomedicine Nanobiotechnology201810e147110.1002/wnan.1471576334128382713Open DOISearch in Google Scholar
National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management, clinical guideline [CG175], 2014. [cited 2019 March 28]. Available at: http://www.nice.org.uk/guidance/cg175/chapter/1-recommendationsNational Institute for Health and Care Excellence. Prostate cancer: diagnosis and management, clinical guideline [CG175]2014[cited 2019 March 28]Available athttp://www.nice.org.uk/guidance/cg175/chapter/1-recommendationsSearch in Google Scholar
Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol 2014; 43: 1503-13. 10.1007/s00256-014-1903-9ShenGDengHHuSJiaZComparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysisSkeletal Radiol2014431503–1310.1007/s00256-014-1903-924841276Open DOISearch in Google Scholar
Padhani AR, Koh D-M, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011; 261: 700-18. 10.1148/radiol.11110474PadhaniARKohD-MCollinsDJWhole-body diffusion-weighted MR imaging in cancer: current status and research directionsRadiology2011261700–1810.1148/radiol.1111047422095994Open DOISearch in Google Scholar
Padhani AR, Lecouvet FE, Tunariu N, Koh D-M, De Keyzer F, Collins DJ, et al. METastasis Reporting and Data System for Prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 2017; 71: 81-92. 10.1016/j.eururo.2016.05.033PadhaniARLecouvetFETunariuNKohD-MDe KeyzerFCollinsDJet alMETastasis Reporting and Data System for Prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancerEur Urol20177181–9210.1016/j.eururo.2016.05.033517600527317091Open DOISearch in Google Scholar
Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 2012; 62: 68-75. 10.1016/j.eururo.2012.02.020LecouvetFEElMouedden JColletteLCocheEDanseEJamarFet alCan whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?Eur Urol20126268–7510.1016/j.eururo.2012.02.02022366187Open DOISearch in Google Scholar
Pasoglou V, Michoux N, Peeters F, Larbi A, Tombal B, Selleslagh T, et al. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology 2015; 275: 155-66. 10.1148/radiol.14141242PasoglouVMichouxNPeetersFLarbiATombalBSelleslaghTet alWhole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic diseaseRadiology2015275155–6610.1148/radiol.1414124225513855Open DOISearch in Google Scholar
Larbi A, Pasoglou V, Triqueneaux P, Cyteval C, Tombal B, Omoumi P, et al. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 2018. [Epub ahead of print]. 10.1007/s00330-018-5796-1LarbiAPasoglouVTriqueneauxPCytevalCTombalBOmoumiPet alWhole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequencesEur Radiol2018[Epub ahead of print]. doi10.1007/s00330-018-5796-130413957Open DOISearch in Google Scholar
